These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36033622)

  • 1. Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer's disease risk.
    Ma J; Qiu S
    Front Neurosci; 2022; 16():926830. PubMed ID: 36033622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between CLU gene rs11136000 polymorphism and Alzheimer's disease: an updated meta-analysis.
    Zhu R; Liu X; He Z
    Neurol Sci; 2018 Apr; 39(4):679-689. PubMed ID: 29396813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CLU gene rs11136000 variant is significantly associated with Alzheimer's disease in Caucasian and Asian populations.
    Liu G; Wang H; Liu J; Li J; Li H; Ma G; Jiang Y; Chen Z; Zhao B; Li K
    Neuromolecular Med; 2014 Mar; 16(1):52-60. PubMed ID: 23892938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing 74,248 Samples Confirms the Association Between CLU rs11136000 Polymorphism and Alzheimer's Disease in Caucasian But Not Chinese population.
    Han Z; Qu J; Zhao J; Zou X
    Sci Rep; 2018 Jul; 8(1):11062. PubMed ID: 30038359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between clusterin gene polymorphism rs11136000 and late-onset Alzheimer's disease susceptibility: A review and meta-analysis of case-control studies.
    Du W; Tan J; Xu W; Chen J; Wang L
    Exp Ther Med; 2016 Nov; 12(5):2915-2927. PubMed ID: 27882096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Link of
    Abdul Aziz M; Md Ashraf G; Safiqul Islam M
    Curr Alzheimer Res; 2022; 19(4):302-316. PubMed ID: 35546756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informative combination of CLU rs11136000, serum HDL levels, diabetes, and age as a new piece of puzzle-picture of predictive medicine for cognitive disorders.
    Aghajanpour-Mir M; Amjadi-Moheb F; Dadkhah T; Hosseini SR; Ghadami E; Assadollahi E; Akhavan-Niaki H; Ahmadi Ahangar A
    Mol Biol Rep; 2019 Feb; 46(1):1033-1041. PubMed ID: 30560405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of clusterin gene (CLU/APOJ) polymorphism in Alzheimer's disease patients and in normal cohorts from Russian populations].
    Golenkina SA; Gol'tsov AIu; Kuznetsova IL; Grigorenko AP; Andreeva TV; Reshetov DA; Kunizheva SS; Shagam LI; Morozova IIu; Goldenkova-Pavlova IV; Shimshilashvili Kh; Viacheslavova AO; Faskhutdinova G; Gareeva AÉ; Zaĭnullina AG; Khusnutdinova ÉK; Puzyrev VP; Stepanov VA; Kolotvin AV; Samokhodskaia LM; Selezneva ND; Gavrilova SI; Rogaev EI
    Mol Biol (Mosk); 2010; 44(4):620-6. PubMed ID: 20873220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease risk variant in CLU is associated with neural inefficiency in healthy individuals.
    Lancaster TM; Brindley LM; Tansey KE; Sims RC; Mantripragada K; Owen MJ; Williams J; Linden DE
    Alzheimers Dement; 2015 Oct; 11(10):1144-52. PubMed ID: 25496871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.
    Zhou Y; Hayashi I; Wong J; Tugusheva K; Renger JJ; Zerbinatti C
    PLoS One; 2014; 9(7):e103187. PubMed ID: 25051234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.
    Roussotte FF; Gutman BA; Madsen SK; Colby JB; Thompson PM;
    J Neurosci; 2014 May; 34(19):6537-45. PubMed ID: 24806679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer's Disease in a Central European Population.
    Balcar VJ; Zeman T; Janout V; Janoutová J; Lochman J; Šerý O
    Neurochem Res; 2021 Feb; 46(2):411-422. PubMed ID: 33206315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LACK OF ASSOCIATIONS BETWEEN CLU AND PICALM GENE POLYMORPHISMS AND ALZHEIMER'S DISEASE IN A TURKISH POPULATION.
    Sen A; Arslan M; Erdal ME; Ay OI; Yilmaz SG; Kurt E; Arpaci B
    Ideggyogy Sz; 2015 Mar; 68(3-4):113-20. PubMed ID: 26434199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between CLU polymorphisms and memory performance: The role of serum lipids in Alzheimer's disease.
    Chen LH; Heng Mak TS; Fan Y; Yin Ho DT; Sham PC; Chu LW; Song YQ
    J Psychiatr Res; 2020 Oct; 129():281-288. PubMed ID: 32882505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity factor contributes to altered brain functional networks in individuals at risk for Alzheimer's disease: Neuroimaging-genetic evidence.
    Bai F; Shi Y; Yuan Y; Xie C; Zhang Z
    Brain Behav Immun; 2016 Aug; 56():84-95. PubMed ID: 26899953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Tan L; Wang HF; Tan MS; Tan CC; Zhu XC; Miao D; Yu WJ; Jiang T; Tan L; Yu JT;
    Sci Rep; 2016 May; 6():26027. PubMed ID: 27229352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer's disease.
    Mullan GM; McEneny J; Fuchs M; McMaster C; Todd S; McGuinness B; Henry M; Passmore AP; Young IS; Johnston JA
    Curr Alzheimer Res; 2013 Nov; 10(9):973-8. PubMed ID: 24117116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.
    Cai R; Han J; Sun J; Huang R; Tian S; Shen Y; Dong X; Xia W; Wang S
    Front Aging Neurosci; 2016; 8():179. PubMed ID: 27516739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals.
    Nordestgaard LT; Tybjærg-Hansen A; Rasmussen KL; Nordestgaard BG; Frikke-Schmidt R
    BMC Med; 2018 Mar; 16(1):39. PubMed ID: 29534716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
    Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
    Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.